DSGN (Design Therapeutics, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by DSGN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | Simeon George | Director | A | — | — |
| 2026-06-11 | RODNEY W LAPPE | Director | A | — | — |
| 2026-06-11 | Heather A. Berger | Director | A | — | — |
| 2026-06-11 | David Shapiro | Director | A | — | — |
| 2026-06-11 | John P. Schmid | Director | A | — | — |
| 2026-06-11 | Justin D. Gover | Director | A | — | — |
| 2026-04-01 | David Shapiro | Director | A | — | — |
| 2026-01-05 | Julie Burgess | Chief Accounting Officer | A | — | — |
| 2026-01-05 | Chris Storgard | Chief Medical Officer | A | — | — |
| 2026-01-05 | Pratik Shah | President, CEO and Chairperson | A | — | — |
| 2026-01-05 | Sean Jeffries | Chief Operating Officer | A | — | — |
| 2026-01-05 | Justin D. Gover | Director | A | — | — |
| 2025-12-11 | Pratik Shah | President, CEO and Chairperson | A | — | — |
| 2025-09-10 | Justin D. Gover | Director | A | — | — |
| 2025-08-14 | Arsani William | Director | Sell | — | — |
| 2025-06-12 | John P. Schmid | Director | A | — | — |
| 2025-06-12 | Simeon George | Director | A | — | — |
| 2025-06-12 | RODNEY W LAPPE | Director | A | — | — |
| 2025-06-12 | Arsani William | Director | A | — | — |
| 2025-06-12 | Deepa Prasad | Director | A | — | — |
| 2025-06-12 | Heather A. Berger | Director | A | — | — |
| 2025-05-23 | Chris Storgard | Chief Medical Officer | A | — | — |
| 2025-01-06 | Pratik Shah | President, CEO and Chairperson | A | — | — |
| 2025-01-06 | Sean Jeffries | Chief Operating Officer | A | — | — |
| 2025-01-06 | RODNEY W LAPPE | Director | A | — | — |
| 2025-01-06 | Julie Burgess | Chief Accounting Officer | A | — | — |
| 2024-12-19 | Deepa Prasad | Director | Sell | — | — |
| 2024-08-12 | Arsani William | Director | Sell | — | — |
| 2024-06-17 | Deepa Prasad | Director | A | — | — |
| 2024-06-17 | Arsani William | Director | A | — | — |
| 2024-06-17 | Simeon George | Director | A | — | — |
| 2024-06-17 | RODNEY W LAPPE | Director | A | — | — |
| 2024-06-17 | Heather A. Berger | Director | A | — | — |
| 2024-06-17 | John P. Schmid | Director | A | — | — |
| 2024-03-25 | John P. Schmid | Director | Buy | — | — |
| 2024-03-25 | Heather A. Berger | Director | Buy | — | — |
| 2024-01-05 | Julie Burgess | Chief Accounting Officer | A | — | — |
| 2024-01-05 | Sean Jeffries | Chief Operating Officer | A | — | — |
| 2023-12-05 | RODNEY W LAPPE | Director | A | — | — |
| 2023-12-05 | Aseem Z. Ansari | 10%+ Owner | A | — | — |
| 2023-10-02 | RODNEY W LAPPE | Director | Buy | — | — |
| 2023-09-06 | Arsani William | Director | MIXED | — | — |
| 2023-09-05 | Pratik Shah | President, CEO and Chairperson | A | — | — |
| 2023-08-30 | Deepa Prasad | Director | Buy | — | — |
| 2023-08-30 | Arsani William | Director | Buy | — | — |
| 2023-06-02 | Deepa Prasad | Director | A | — | — |
| 2023-06-02 | RODNEY W LAPPE | Director | A | — | — |
| 2023-06-02 | John P. Schmid | Director | A | — | — |
| 2023-06-02 | Stella Xu | Director | A | — | — |
| 2023-06-02 | Arsani William | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 6,526,476 | — |
| — | Director | 6,486,476 | — |
| — | 10%+ Owner | 5,626,476 | — |
| — | 10%+ Owner | 4,439,839 | — |
| — | — | 4,364,844 | — |
| — | Director | 4,168,605 | — |
| — | Director | 1,000,000 | — |
| — | President, CEO and Chairperson | 154,923 | — |
| — | Director | 133,024 | — |
| — | President and CEO | 126,319 | — |
| — | Director | 57,639 | — |
| — | Director | 20,000 | — |
| — | Vice President, Finance | 17,500 | — |
| — | Chief Operating Officer | 3,050 | — |
| — | Director | 1,300 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the DSGN quote page; the site-wide leaderboard is on the insider transactions hub.